ALVOTECH
Alvotech strongly disputes AbbVie’s allegations of wrongdoing relating to AVT02, Alvotech’s proposed biosimilar to HUMIRA® (adalimumab). Alvotech will vigorously defend against these allegations.
Notably, AbbVie waited over three years from the purported date of the alleged wrongdoing to file its case, doing so after the ex-AbbVie employee had already left Alvotech and without naming the ex-AbbVie employee as a defendant.
This lack of urgency causes Alvotech to question the motivation behind the case. Indeed, Alvotech believes that the case may be part of a larger AbbVie strategy to delay an emerging competitor from providing patients with a lower-cost alternative to AbbVie’s HUMIRA® high-concentration product.
Alvotech will continue its efforts to increase accessibility to high quality and affordable medicines.
About Alvotech:
Alvotech is a multinational biopharmaceutical company focused on the development and manufacture of high quality biosimilars for global markets. We are specialists in biotechnology, seeking to be a global leader in the biosimilar space by delivering high quality, cost-competitive products and services to our partners and to patients worldwide. Our fully integrated approach, with high-quality in-house competencies throughout the value chain, enables the accelerated development of biosimilar products. Alvotech’s shareholder base includes, among others, Aztiq Pharma, led by founder and Chairman Mr. Robert Wessman, Cipla Gulf FZ from Australia and New Zeland, Shinhan from Korea, Baxter Healthcare SA, YAS Holdings, ATHOS (Strüngmann Family Office), CVC Capital Partners and Temasek from Singapore.
Alvotech‘s initial pipeline contains several monoclonal-antibody and fusion-protein biosimilar candidates aimed at treating autoimmunity, oncology and inflammatory conditions to improve quality of life for patients around the world. For more information, please visit our website, www.alvotech.com or follow us on LinkedIn , Twitter and Facebook.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210325005659/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
IonQ to Highlight Real-World Quantum Applications at Web Summit 202512.11.2025 13:05:00 CET | Press release
IonQ’s Dr. Chris Ballance to speak on how fidelity breakthroughs are accelerating practical use cases and quantum advantage IonQ (NYSE: IONQ), the world’s leading quantum company, today announced its participation in Web Summit 2025, one of the largest technology events in Europe. IonQ’s President of Quantum Computing and co-founder of Oxford Ionics, Dr. Chris Ballance, is scheduled to speak during the conference’s AI Summit on Thursday, November 13, 2025, at 10:30 AM local time. The AI Summit session, “Quantum Without Compromise: The Race to Real-world Applications,” will be moderated by technology journalist, Mary-Ann Russon. The discussion will focus on IonQ’s recent breakthroughs in quantum gate fidelity and how these advancements underpin the company’s roadmap toward fault-tolerant systems. Dr. Ballance will also share how these engineering accomplishments translate into quantum computing’s growing impact across industries. “We’re at a pivotal moment where breakthroughs in quantum
Ananda Scientific and Benta Sign Memorandum on Advancing Treatments for PTSD12.11.2025 13:04:00 CET | Press release
Ananda Scientific Inc., a clinical-stage drug development company advancing innovative therapies for high-impact neuropsychiatric disorders, today announced the signing of a Memorandum of Understanding (MOU) with Benta SAS. The MOU expresses the parties’ intent to explore a potential collaboration focused on accelerating the development and future availability of a new treatment for Post-Traumatic Stress Disorder (PTSD) in Europe and the Middle East/North Africa (MENA) region. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251112416172/en/ PTSD is a chronic and debilitating condition that affects millions of people worldwide. Despite its significant prevalence and devastating impact on patients, families, and communities, there has been no new approved drug for PTSD in over two decades — underscoring a critical unmet medical need. As part of its clinical development pipeline, Ananda Scientific is currently advancing Nantheia
Global Airline Reliability Improves in October, Led by Asia-Pacific as North America Faces Operational Pressures; Cirium Analysis12.11.2025 13:00:00 CET | Press release
Cirium, the world’s most trusted source of aviation analytics, has published its October 2025 On-Time Performance (OTP) Report, covering more than 370,000 flights with 99.8% global coverage. The data indicates a 26% reduction in global cancellations compared with September, reflecting improved operational stability across the commercial aviation network. The results also highlight distinct regional dynamics shaping airline performance worldwide. Asia-Pacific carriers led the recovery, cutting flight cancellations by 43% as airlines across Japan, South Korea, and the Philippines strengthened network performance and capacity. Notably, the world’s top-performing airports in October — Harbin Taiping and Changchun Longjia in China, and Kaohsiung International in Taiwan — were all located in the region, underscoring its continued operational gains and steady recovery momentum. North American operations showed greater operational strain, with flight cancellations rising by about 12.6% month o
New Study Further Validates Environmental Benefits of Floor Refinishing Compared to Replacement12.11.2025 12:00:00 CET | Press release
Renovation of hard flooring surfaces, such as wood and resilient, saves up to 92 percent in CO2 emissions and up to 98 percent in energy usage A recent report and lifecycle assessment (LCA) conducted by IVL Swedish Environmental Research Institute confirms refinishing hard flooring surfaces, including wood, vinyl and linoleum, is more sustainable for the environment than replacing the flooring surfaces. This new study, which was conducted for the German market, is the next step of research inspired from a previous 2019 study conducted in Sweden. Both studies aim to evaluate the environmental impact of replacing a worn, damaged or outdated flooring surface compared to refinishing the flooring surface which may include sanding, finishing, staining, or painting. Bona, a global, family-owned company that supplies products for installing, renovating, maintaining, and restoring premium floors, commissioned this new study to build on the findings from a 2019 Swedish study. The new research fo
PUMA Relaunches Company Magazine CATch UP to Showcase the Best of the Brand12.11.2025 10:00:00 CET | Press release
Sports company PUMA has relaunched its online company magazine CATch UP to provide journalists, investors, retailers, athletes and sports enthusiasts with a window into the world of PUMA and insights into the company’s new strategic priorities, as the brand starts its transformation journey. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251112815459/en/ Sports company PUMA has relaunched its online company magazine CATch UP to provide journalists, investors, retailers, athletes and sports enthusiasts with a window into the world of PUMA and insights into the company’s new strategic priorities, as the brand starts its transformation journey. The online magazine, which is available on puma-catchup.com, has received a thorough visual makeover and will focus on the stories that highlight the company’s innovations, sports, history, corporate culture and the strategic priorities that are being implemented to establish PUMA as a T
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom